The effect of cancer drug vintage on cancer survival and mortality

Annals of Oncology

Volumn 18, Issue SUPPL. 3, 2007, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; ANTINEOPLASTIC AGENT; ASPARAGINASE; ASPARAGINASE MACROGOL; CARBOPLATIN; CISPLATIN; DACTINOMYCIN; DAUNORUBICIN; DENILEUKIN DIFTITOX; DOCETAXEL; FLOXURIDINE; FLUOROURACIL; GEMCITABINE; GEMTUZUMAB OZOGAMICIN; IFOSFAMIDE; IRINOTECAN; METHOTREXATE; NAVELBINE; NEW DRUG; PACLITAXEL; PENTOSTATIN; RAZOXANE; RITUXIMAB; STREPTOKINASE; STREPTOZOCIN; TEMOZOLOMIDE; THIOTEPA; TOPOTECAN; TRASTUZUMAB; UNINDEXED DRUG;

ARTICLE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CORRELATION ANALYSIS; DATA ANALYSIS; DRUG USE; HEALTH STATUS; HUMAN; HYPOTHESIS; LONGEVITY; PRIORITY JOURNAL; SURVIVAL RATE; UNITED STATES;

EID: 54349123621     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm102     Document Type: Article

References (8)

1. Grossman GM, Helpman E. Innovation and Growth in the Global Economy. Cambridge: MIT Press 1993.
2. Bresnahan TF, Gordon RJ. The Economics of Now Goods. Chicago, IL: University of Chicago Press 1996.
3. Bils M. Measuring the growth from better and better goods. NBER Working Paper No. 10606. http://www.nber.org/papers/w10606.
4. Lichtenberg F. Pharmaceutical knowledge-capital accumulation and longevity. In Corrado C, Haltiwanger J, Sichel D (eds): Measuring Capital in the New Economy. University of Chicago Press 2005; 237-269.
5. Lichtenberg F. Availability of new drugs and Americans' ability to work. J Occup Environ Med 2005; 47: 373-380.
6. Lichtenberg F. The impact of new drug launches on longevity: Evidence from longitudinal disease-level data from 52 countries, 1982-2001. Int J Health Care Finance Econ 2005; 5: 47-73.
7. Lichtenberg F. The impact of increased utilization of HIV drugs on longevity and medical expenditure: An assessment based on aggregate U.S. time-series data. Exp Rev Pharmacoecon Outcomes Res 2006; 6: 425-436.
8. Lichtenberg F. The Expanding Pharmaceutical Arsenal in the War on Cancer, NBER Working Paper No. 10328, February 2004, http://www.nber.org/ papers/w10328.